Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.720
+0.010 (0.58%)
At close: Nov 6, 2026, 4:00 PM EST
1.730
+0.010 (0.58%)
After-hours: Nov 6, 2026, 7:30 PM EST
Zentalis Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
106
Market Cap
162.84M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 67.43M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Invivyd | 58.37M |
| Sutro Biopharma | 45.70M |
| Entrada Therapeutics | 3.98M |
| Upstream Bio | 3.16M |
| Oramed Pharmaceuticals | 2.00M |
ZNTL News
- 5 days ago - Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 days ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 10 days ago - Zentalis price target lowered to $7 from $8 at Mizuho - TheFly
- 16 days ago - Zentalis announces median OS data from DENALI Part 1b study - TheFly
- 16 days ago - Zentalis Pharmaceuticals Announces Meaningful Median Overall Survival Data in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer from DENALI Part 1b to be Presented at the ESMO Congress 2026 - GlobeNewsWire
- 21 days ago - Zentalis announces first OS data from DENALI part 1b study - TheFly
- 21 days ago - Zentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 Abstract - GlobeNewsWire
- 4 weeks ago - Zentalis assumed at Outperform from Market Perform at Leerink - TheFly